Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: LabMD to Distribute Mitomics' Prostate Test; Lab21's NSCLC Companion Dx Test

Premium

Mitomics said this week that it has signed a non-exclusive agreement with LabMD to market its Prostate Core Mitomic Test in the US.

LabMD, an Atlanta-based clinical pathology laboratory, will distribute the test to its urology customers for patients with suspected prostate cancer who have a negative initial biopsy outcome.

PCMT is a PCR-based mitochondrial DNA test that detects the presence of cancerous cells using previously obtained prostate biopsy tissue.

Mitomics said the test has sensitivity of 84 percent and can accurately rule out prostate cancer with a negative predictive value of 91 percent.


Lab21, a personalized medicine diagnostics firm based in Cambridge, UK, has launched an EML4-ALK companion diagnostic testing service for non-small cell lung cancer patients.

The service will offer PCR-based testing for translocations in the ALK gene associated with response to ALK inhibitor therapy.

Lab21 will perform the test in its accredited laboratories in Cambridge. The test adds to companion diagnostics that the company already offers for portfolio KRAS, EGFR, and BRAF mutation analysis.

Clinical trials have shown that NSCLC patients with translocations in the ALK gene have a better outcome when treated with an ALK inhibitor. Approximately 5 percent of NSCLC patients harbor an ALK translocation and more than 80 percent of those are with the EML4 gene, Lab21 said.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.